million or increase 232.3%, due to the company has improved its production efficiency and gain from sale of flexible packaging. 3. Selling expenses In year 2017, the selling expenses was Baht 9.96 million
249.10 (32) Less Loss on derivatives 92.95 - n.a. Loss on change in status of investments 5.72 - n.a. Share of profit (loss) from investment in (0.14) 5.30 103 joint ventures Gain (loss) on recognition of
pandemic has an immense impact on all of us. For the past year, governments across the globe have been fighting against the pandemic and eventually managed to contain the spread of the virus and more
net loss includes unrealized loss on foreign exchange of 19.29 million baht. Comparing with last year, the Company had a net loss of 64.72 million baht which includes unrealized gain on foreign exchange
had a net loss of 34.71 million baht in which there is a loss attributable for the equity holders of the Company of 34.72 million baht and the net loss includes an unrealized gain on foreign exchange of
robust operational performance across all our assets. The on-going structural changes in the PET industry created opportunity for well-managed and committed producers to align supply reliability and
result Million Baht 2019 2018 Sales 1,748.29 1,905.09 Cost of Sales 1,636.11 1,756.98 Gross Margin 112.17 148.11 Gain (loss) on exchange rates 38.44 (26.43) Other Incomes 33.76 30.28 Total Revenues
result Million Baht 2018 2017 Sales 1,905.09 1,849.88 Cost of Sales 1,756.98 1,621.03 Gross Margin 148.11 228.85 Gain (loss) on exchange rates (26.43) 23.44 Other Incomes 30.28 27.42 Total Revenues
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Company and its subsidiaries consists of agent fee income, interest income, gain on exchange rate and gain on short-term investment. For the three-month period ended 31 March 2019, other income totaled THB